Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Hepatitis C: Another “Child” of the Drug Industry, Says Ohio’s Yes on Issue 2 Campaign

Ohio Taxpayers for Lower Drug Prices
Posted on: 09 Sep 17

PhRMA’s own opioid drug makers, like Purdue, Teva and Johnson & Johnson, now have more blood on their hands. Because of the opioid and heroin epidemic these drug companies fueled, the U.S. now has a growing hepatitis C epidemic, shared dirty needles being a prime vehicle for spreading this disease.

The Centers for Disease Control and Prevention (CDC) estimates the U.S. had 34,000 new cases of hepatitis C in 2015, triple the numbers from 2010. Hepatitis C killed 20,000 Americans last year, making it the nation’s most deadly disease.

Source: Huffington Post and Centers for Disease Control and Prevention report.

Background on Ohio Ballot Issue 2

The Yes on Issue 2 campaign is a broad-based, bi-partisan coalition. More than 200,000 Ohio voters signed petitions to put an amendment on the ballot in November that will lower drug prices for over 4 million Ohioans, including 164,000 children, save taxpayers $400 million annually, reduce healthcare costs for everyone and teach greedy drug companies and their CEOs a lesson.

You can learn more by visiting yesonissue2.com or following us on Facebook and Twitter.

Paid for by Ohio Taxpayers for Lower Drug Prices

View source version on businesswire.com: http://www.businesswire.com/news/home/20170908005984/en/

Business Wire
www.businesswire.com

Last updated on: 09/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.